FÜR RISIKOBEWERTUNG BUNDESINSTITUT. MRLs for Biocides Establishment of an EU-wide Procedure
|
|
- Cecily Cobb
- 6 years ago
- Views:
Transcription
1 BUNDESINSTITUT FÜR RISIKOBEWERTUNG MRLs for Biocides Establishment of an EU-wide Procedure Isabel Günther Federal Institute for Risk Assessment, Berlin, Germany Biocides 2013, Vienna
2 Introduction Certain uses of biocides can lead to residues in food, e.g. - Disinfectants in the food industry or in homes (PT 4) - Disinfectants incorporated into food contact materials (PT 4) - Insecticides in the food industry, in homes or in animal housing (PT 18) - Products for veterinary hygiene (PT 3) - In-can preservatives, e.g. in dishwashing detergents (PT 6) When residues in food occur, MRLs must be set. For biocides, an EU-wide procedure for setting MRLs has yet to be established. Several unresolved issues regarding such a procedure have been identified and will be explained in this presentation.
3 Regulatory Framework for Biocide MRLs MRL setting is required by Regulation (EU) No 528/ Art. 19(1)(e) where appropriate Applications in animal husbandry - EMA: Reg. (EC) No 470/2009 (veterinary medicinal products) All other biocidal applications - EFSA: Reg. (EC) No 396/2005 (pesticide residues) - Reg. (EEC) No 315/93 (food contaminants) - Reg. (EC) No 1935/2004 (food contact materials) - Dir. 2002/32/EC (undesirable substances in animal feed)
4 Regulatory Framework for Biocide MRLs Points to consider: Unclear which use falls under which legal framework. So far only defined for Reg. (EC) No 470/2009. Guidance needed For dual-/triple-use active substances, two or more sets of MRLs are set, which may have different values and which may not account for residues from the other uses. Effective communication necessary within EFSA and between EFSA and EMA to avoid this situation
5 Regulatory Framework for Biocide MRLs Points to consider: The MRL-setting procedures under the respective legal frameworks differ from each other: - Some involve national MS authorities, others only EU authority (EFSA), EMA appoints experts - Submission formats for application and dossier - Data requirements - Assessment concepts
6 Differences between Regulatory Frameworks Place of submission: 470/2009: MRL application submitted to EMA; evaluation by EMA-appointed rapporteur from CVMP (not member state) with help from experts 396/2005: MRL application submitted to MS; evaluation by MS and then by EFSA 1935/2004: SML application submitted to MS; evaluation by EFSA The other legal frameworks: evaluation by EFSA How can it be ensured that applicants know where to submit? Will guidance be made available?
7 Differences between Regulatory Frameworks Formats: Each framework uses different submission formats for application and dossier What formats will be used for biocide MRL applications? -Will existing formats be amended to include biocides? -Will a new format for biocides be created and apply across legal frameworks?
8 Differences between Regulatory Frameworks Assessment concepts: Toxicological reference values Plant protection products ADI and ARfD Veterinary drugs ADI (based on chronic and acute endpoints) Residue intake Chronic and acute Chronic only Consumption data National consumption data from EU member states Daily food basket (based on arbitrarily fixed high values ) All other biocidal applications? Biocidal applications in animal husbandry MRLs checked against different exposures and reference values
9 Differences between Regulatory Frameworks Other open questions: An MRL evaluation concept is so far only available for uses in animal husbandry (Reg. (EU) No 470/2009). Reg. (EU) No 470/2009 has been amended to include biocides. Reg. (EC) No 396/2005 is currently being amended to include biocides. Will the other legal texts be amended as well?
10 Coordination of MRL Evaluations MRL applications with same active substance submitted by many different companies and often in more than one Member State. AS a BP x (AP x) BP y (AP y) BP z (AP z) MRLs for AS a Effective co-ordination necessary! - Which authority? - Which database: R4BP? EFSA Extranet?
11 Timeframe for MRL Setting for Biocides Four scenarios: 1. MRL application is submitted prior to BP application (shortly after active substance approval) 2. MRL and product applications are submitted at the same time 3.MRL application submitted after BP application (necessity for MRLs seen seen during BP BP evaluation) 4. MRL application submitted after BP application (necessity for MRLs seen during mutual recognition)
12 Safe use MRL Timeframe for MRL Setting for Biocides Art. 19(1)(e): A biocidal product shall be authorised provided the following conditions are met: where appropriate, maximum residue limits have been established MRLs must be set before a biocidal product can be authorised. Authorising MS EMA / EFSA DRA finds MRLs needed MRL setting Authorisation 1 year
13 Timeframe for MRL Setting for Biocides Experience with plant protection products and veterinary medicinal products shows that it takes at least 1 year to evaluate MRL application and set MRLs. Not possible to set MRLs in time for BP authorisation no authorisation BP has to be taken off market Transition rules may be needed (e.g. temporary marketing permission without MRLs; establishment of temporary high MRLs based only on rough health assessment)
14 Timeframe for MRL Setting for Biocides Proposal: It would be most effective to set MRLs after collecting all possible uses of an active substance and set MRLs for the most critical use. Advantage: One MRL evaluation rather than several (with each BP application) Disadvantage: Information only available after BPs have been assessed during national authorisation. Transition rules needed.
15 MRL Workshop in March 2014 Many open questions! To discuss these open questions and propose solutions, the German Federal Institute for Risk Assessment with support of COM is organising a workshop. When: March 2014 (probably 18th-19th) Programme: Presentations on the existing procedures, working groups for discussion and development of recommendations on specific open questions Content: Topics to be discussed are currently being developed by a preparations committee
16 BUNDESINSTITUT FÜR RISIKOBEWERTUNG Thank you for your attention! Isabel Günther Federal Institute for Risk Assessment Max-Dohrn-Str D Berlin
FÜR RISIKOBEWERTUNG MRLs for Biocides Establishment of an EU-wide Procedure
BUNDESINSTITUT FÜR RISIKOBEWERTUNG MRLs for Biocides Establishment of an EU-wide Procedure Biocides 2014, Vienna Isabel Günther Federal Institute for Risk Assessment, Berlin, Germany Introduction Certain
More informationSummary Report of the European Conference on MRL Setting for Biocides
Summary Report of the European Conference on MRL Setting for Biocides Conference report, 8 December 2014 In March 2014, the Federal Institute for Risk Assessment in Germany (BfR) together with the European
More informationVeterinary Medicines Legislation and Maximum Residue Limits in the EU
OIE Belgrade, 26 July 2010 Veterinary Medicines Legislation and Maximum Residue Limits in the EU Mario Nagtzaam EC, DG SANCO, Unit C8 Pharmaceuticals Outline Institutions of the European Union European
More informationCurrent activities of the European Commission in the area of pesticide residues
4th Joint Workshop of the European Union Reference Laboratories - 23rd - 25th October 2013 Current activities of the European Commission in the area of pesticide residues Veerle Vanheusden Introduction
More informationImport tolerances in the European Union Can Import Tolerances be set for active substances impacted by the EU hazard-based criteria?
Import tolerances in the European Union Can Import Tolerances be set for active substances impacted by the EU hazard-based criteria? May 2017 Abstract The aim of this paper is to provide information on
More informationAuthorisation procedure for plant protection products. Description of the procedure for applications for zonal authorisations in Germany
Authorisation procedure for plant protection products Description of the procedure for applications for zonal authorisations in Germany Contact address: Bundesamt für Verbraucherschutz und Lebensmittelsicherheit
More informationCore member of a Biocidal Products Committee Working Group
Core member of a Biocidal Products Committee Working Group Working Group (tick as appropriate): Efficacy Add your photo here! Analytical Methods Physico-chemical Properties Human Health Environment 1.
More informationBUNDESINSTITUT FÜR RISIKOBEWERTUNG
BUNDESINSTITUT FÜR RISIKOBEWERTUNG Mehrfachrückstände von Pflanzenschutzmitteln in Lebensmitteln Teil III Internationale Bewertungskonzepte für Mehrfachrückstände 10.11.2005 Cumulative Risk Assessment:
More informationAustria: Experiences with the Zonal evaluation procedure Applying Regulation (EC) No.1107/2009
Austria: Experiences with the Zonal evaluation procedure Applying Regulation (EC) No.1107/2009 Vienna, Ceureg Meeting, 15-16 October 2012 Rebecca Reboul Institute for Plant Protection Products AGES, Austrian
More informationPLANT PROTECTION DIRECTORATE. Department for Plant Protection (PPP`s) and Plant Nutrition Products (PNP`s) MUTUAL RECOGNITION
Republic of Serbia Ministry of Agriculture, Forestry and Water Management PLANT PROTECTION DIRECTORATE Plant Protection (PPP`s) and Plant Nutrition Products (PNP`s) MUTUAL RECOGNITION Omladinskih brigada
More informationPharmacovigilance- Content of the New EU Legislation and Challenges for BfArM
Pharmacovigilance- Content of the New EU Legislation and Challenges for BfArM 12 th DGRA Annual Congress June 15 to 16, Bonn U. Hagemann Bundesinstitut für Arzneimittel und Medizinprodukte BfArM Visit
More informationSTANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENETICALLY MODIFIED FOOD AND FEED AND ENVIRONMENTAL RISK
STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENETICALLY MODIFIED FOOD AND FEED AND ENVIRONMENTAL RISK SUMMARY RECORD OF THE 2 nd MEETING 23 June 2004 Chairman Mr. Patrick Deboyser
More informationMandate, objectives and rules of procedure for the CVMP Ad Hoc Expert Group on Veterinary Novel Therapies (ADVENT)
6 October 2016 EMA/CVMP/ADVENT/630299/2014 Rev.2 Committee for Medicinal Products for Veterinary Use (CVMP) Mandate, objectives and rules of procedure for the CVMP Ad Hoc Expert Group on Veterinary Novel
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY COMMISSION GUIDANCE DOCUMENT 1
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Safety of the Food Chain Pesticides and Biocides COMMISSION GUIDANCE DOCUMENT 1 SANCO/12184/2014 rev. 5.1 14 July 2015 Guidance Document
More informationRegulatory framework for seed treatments in the EU
Pesticide risks for pollinators 8th SETAC Europe Special Science Symposium Brussels, 16-17 October 2013 Regulatory framework for seed treatments in the EU Gunilla Ericson European Commission Directorate
More informationDraft agreed by Environmental Risk Assessment Working Party (ERAWP) 31 May Adopted by CVMP for release for consultation 12 July 2012
10 September 2015 EMA/CVMP/ERA/52740/2012 Committee for Medicinal Products for Veterinary Use (CVMP) Guideline on the assessment of persistent, bioaccumulative and toxic (PBT) or very persistent and very
More information10041/16 ADD 1 GSC/lt 1 DG B 2B
Council of the European Union Brussels, 10 June 2016 (OR. en) 10041/16 ADD 1 AGRI 320 PHYTOSAN 12 PESTICIDE 1 NOTE From: To: Subject: Presidency Delegations Acceleration of Sustainable Plant Production
More informationEU Food Law. protect public health (human, animal and plant);
EU Food Law The frame for the EC food safety legislation was given by the Article 3 of the Rome Treaty (1957) to assure the free movement of products within the common market. Based on that, the general
More informationGuidance on applications for technical equivalence
1 guidance Guidance on applications for technical equivalence Guidance on Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products Version 1.0 August 2013
More informationCMD(h) GUIDANCE FOR MAHs ON THE PHARMACOVIGILANCE SYSTEM AND RISK MANAGEMENT PLAN IN THE MUTUAL RECOGNITION & DECENTRALISED PROCEDURES
CMD(h) GUIDANCE FOR MAHs ON THE PHARMACOVIGILANCE SYSTEM AND RISK MANAGEMENT PLAN IN THE MUTUAL RECOGNITION & DECENTRALISED PROCEDURES 1. INTRODUCTION (BACKGROUND) November 2007 According to Article 8
More informationCOMMISSION IMPLEMENTING REGULATION (EU) /... of XXX
EUROPEAN COMMISSION Brussels, XXX SANTE/10440/2017 Rev. 2 [ ](2017) XXX draft COMMISSION IMPLEMENTING REGULATION (EU) /... of XXX renewing the approval of the active substance glyphosate in accordance
More informationFunctioning of the PRAC
Functioning of the PRAC Sixth Stakeholders forum on the implementation of the new Pharmacovigilance legislation, November 8 th 2012 Presented by: Almath Spooner Vice Chair, Pharmacovigilance Risk Assessment
More informationUmsetzung des Review 2004 Auswirkungen auf das Europäische Zulassungssystem insbesondere auf das dezentrale und das MR-Verfahren
Umsetzung des Review 2004 Auswirkungen auf das Europäische Zulassungssystem insbesondere auf das dezentrale und das MR-Verfahren DGRA - Jahreskongress, Bonn Bundesministerium für Gesundheit und Frauen
More informationProgress Report on the Implementation of PPPs Regulations in Republic of Croatia CEUREG FORUM XVIII MEETING
Progress Report on the Implementation of PPPs Regulations in Republic of Croatia MEETING Congress Centre Hotel IOR, Poznań, Poland 16th-17th October 2014 Organization of national competent authority Report
More informationAdoption by CHMP for release for 3-month public consultation 18 November End of consultation (deadline for comments) 28 February 2011
18 October 2012 EMA/651649/2010 Committee for Medicinal Products for Human Use Reflection paper on considerations given to designation of a single stereo isomeric form (enantiomer), a complex, a derivative,
More informationProcedure and experience in Germany
www.pei.de National Competent Authorities experience with Environmental Risk Assessment (ERA) before setting clinic trials Procedure and experience in Germany Brigitte Anliker 5th Annual Regulatory Conference
More informationThe Federal Institute of Risk Assessment at a glance dates, facts and background
The Federal Institute of Risk Assessment at a glance dates, facts and background BfR-Background information, 1 Juli 2017 Does aluminium in antiperspirants or arsenic in rice cause a health risk? What is
More informationGUIDANCE DOCUMENT ON WORK-SHARING IN THE NORTHERN ZONE IN THE AUTHORISA- TION OF PLANT PROTECTION PRODUCTS
GUIDANCE DOCUMENT ON WORK-SHARING IN THE NORTHERN ZONE IN THE AUTHORISA- TION OF PLANT PROTECTION PRODUCTS Version 6.0. This guidance document replaces the version of April 2016 and can be voluntarily
More informationReflection paper on risk mitigation measures related to the environmental risk assessment of veterinary medicinal products
1 2 3 10 May 2011 EMA/CVMP/ERAWP/409328/2010 Committee for Medicinal Products for Veterinary Use (CVMP) 4 5 6 7 Reflection paper on risk mitigation measures related to the environmental risk assessment
More informationCOUNCIL DIRECTIVE of 15 July 1991 concerning the placing of plant protection products on the market (91/414/EEC) (OJ L 230, , p.
1991L0414 EN 01.02.2007 016.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COUNCIL DIRECTIVE of 15 July 1991 concerning
More informationZulassung von Biozid-Produkten
Zulassung von Biozid-Produkten Änderungen durch die EU-Biozid-Produkte-Verordnung Emrah Turudu Overview Biocidal Products Directive Biocidal Products Regulation (draft version March 2012) The two-stage
More informationGuidance on the Biocidal Products Regulation
G U I D A N C E Guidance on the Biocidal Products Regulation Volume V, Guidance on applications for technical equivalence Version 1.1 March 2017 2 Guidance on BPR: Volume V Version 1.1 March 2017 Legal
More informationPesticide Regulation System in Japan
Pesticide Regulation System in Japan Atsuko HORIBE 1 st Risk Assessment Division Food Safety Commission Secretariat Cabinet Office atsuko.horibe@cao.go.jp http://www.fsc.go.jp/english/index.html Contents
More informationQUESTIONS AND ANSWERS ON MRP & DCP AND EU ENLARGEMENT
QUESTIONS AND ANSWERS ON MRP & DCP AND EU ENLARGEMENT Doc. Ref.: CMDh/274/2012, Rev3 NovemberRev4 December 2012 QUESTIONS AND ANSWERS ON MRP & DCP AND EU ENLARGEMENT... 1 Where can guidance and recommendations
More informationGuideline on good pharmacovigilance practices (GVP)
22 June 2012 EMA/816573/2011 Guideline on good pharmacovigilance practices (GVP) Module II Pharmacovigilance system master file Draft finalised by the Agency in collaboration with Member States and submitted
More informationRecent Developments in Community Residue Control Legislation
Recent Developments in Community Residue Control Legislation Gerhard Rimkus, DG SANCO, Unit E3 CRL workshop Bilthoven, 15 October 2007 1 Outline Follow-up of the Reflection paper Dir 96/22/EC Dir 96/23/EC
More informationFOR RISK ASSESSMENT FEDERAL INSTITUTE. Has the nature of risks changed? New challenges for regulatory authorities" Reiner Wittkowski
FEDERAL INSTITUTE FOR RISK ASSESSMENT Has the nature of risks changed? New challenges for regulatory authorities" Reiner Wittkowski Main goal: safe foods According EC No. 178/2002 article 14 food is not
More informationUpdate from the Commission: latest developments in the biocides field
Update from the Commission: latest developments in the biocides field Comité d avis sur les produits biocides Adviescomité inzake biociden Forum du 30/11/2017 Brussels Dr Alfonso Las Heras, DVM, PhD European
More informationDirective (EU) 2015/412 Allowing Member States to restrict or prohibit the cultivation of GMOs in their territory
Directive (EU) 2015/412 Allowing Member States to restrict or prohibit the cultivation of GMOs in their territory Thomas Brégeon Unit "Biotechnology" DG Health and Consumers EU legislative framework on
More informationDISCOVER OUR SEGMENT REGULATORY SCIENCE
DISCOVER OUR SEGMENT REGULATORY SCIENCE Our focus In the demanding regulatory environment of the EU, expert knowledge is essential to gaining approval for substances and products. That is why the scientific
More informationSeminar on «EU Plant Health
Seminar on «EU Plant Health Requirements» Bangkok, 21 October 2011 Quick view on the EU pesticide residue legislation Dionyssis Vlachos Dionyssis Vlachos Ministry of Rural Development and Food, Greece
More informationECHA policy for prevention of conflicts of interest
ECHA policy for prevention of conflicts of interest EP workshop 21 February 2013 Geert Dancet Executive Director ECHA INTERNAL 2/21/2013 2 Driving Legislation for ECHA REACH adopted in December 2006 ECHA
More informationMonthly statistics report: December 2017
19 January 2018 EMA/39932/2018 Information Management Division Medicinal products for human use (cumulative figures for the year to date) This document provides current information related to the volume
More informationEuropean Biocidal Products Forum A.I.S.E. & EBPF SURVEY BPR IMPACT ON BIOCIDAL PRODUCTS AND INNOVATION
European Biocidal Products Forum A.I.S.E. & EBPF SURVEY BPR IMPACT ON BIOCIDAL PRODUCTS AND INNOVATION Report December 2015 List of acronyms used in this report AS: Active Substance BP: Biocidal Product
More information(Acts whose publication is obligatory) DIRECTIVE 98/8/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 16 February 1998
EN Official Journal of the European Communities L 123/1 I (Acts whose publication is obligatory) DIRECTIVE 98/8/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 16 February 1998 concerning the placing
More informationBPR update: Union Authorisation, Families and Same Biocidal Product
BPR update: Union Authorisation, Families and Same Biocidal Product Marcel Hulsman Ctgb Account Manager Biocides Brussels, 24 November 2016 Outline Ctgb Union Authorisation Biocidal Product Family Same
More informationThis document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
1998L0008 EN 19.06.2006 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B DIRECTIVE 98/8/EC OF THE EUROPEAN PARLIAMENT
More informationGuidance on the application of mutual recognition in Norway
Guidance on the application of mutual recognition in Norway Under regulation (EC) No. 1107/2009 Norwegian Food Safety Authority Region Office, Greater Oslo Region Official in charge: Tor Erik Jørgensen
More informationThis document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
2012R0528 EN 25.04.2014 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B REGULATION (EU) No 528/2012 OF THE EUROPEAN PARLIAMENT
More informationDr. Eva Lechtenberg-Auffarth The Biocide Directive as a new chance for the Protection of Workers
The Biocide Directive as a new chance for the Protection of Workers Regulatory Framework for Worker Protection Article 137 Article 95 Safe Handling 98/24/EC 2004/37/EC use of PPE 89/656/EEC Classification
More informationEUROPE S BIOCIDAL PRODUCTS DIRECTIVE: BENEFITS AND COSTS IN URBAN PEST MANAGEMENT
Proceedings of the Fifth International Conference on Urban Pests Chow-Yang Lee and William H. Robinson (editors), 2005. Printed by Perniagaan Ph ng @ P&Y Design Network, Malaysia. EUROPE S BIOCIDAL PRODUCTS
More informationTechnical Notes for Guidance on. Dossier Preparation including preparation and evaluation of study summaries
Technical Notes for Guidance on Dossier Preparation including preparation and evaluation of study summaries under Directive 98/8/EC Concerning the Placing of Biocidal Products on the Market 28 March 2002
More informationFinal Minutes of the Biocides Technical Meeting TM II 08 in Arona, June 2008
Final Minutes of the Biocides Technical Meeting TM II 08 in Arona, 10-12 June 2008 INTRODUCTION 1. Approval of the agenda The meeting was chaired by E. van de Plassche and for specific items on the agenda
More informationDECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL) Federal Office of Consumer Protection and Food Safety Mauerstraße 39-42 10117 Berlin (Germany) DECENTRALISED PROCEDURE PUBLICLY AVAILABLE
More informationThe European Medicines Agency: a model of patient/consumer interaction
The European Medicines Agency: a model of patient/consumer interaction V International Conference on patient safety Juan García Burgos Head of Public Information and Stakeholder Networking - Medical Information
More informationSubmission of comments on 'Reflection paper on the use of extrapolation in the development of medicines for paediatrics' (EMA/199678/2016)
11 January 2018 Submission of comments on 'Reflection paper on the use of extrapolation in the development of medicines for paediatrics' (EMA/199678/2016) Comments from: Name of organisation or individual
More informationAdoption by CVMP for release for consultation 11 November End of consultation (deadline for comments) 31 May 2010
15 November 2010 EMA/CVMP/516817/2009 Committee for Medicinal Products for Veterinary Use (CVMP) Guideline on data to be provided in support of a request to include a substance in the list of substances
More informationOzone as active substance under the Biocidal Products Regulation
Ozone as active substance under the Biocidal Products Regulation International Ozone Association World Congress & Exhibition Barcelona June 28 July 3, 2015 Bernhard Paolini Chairman EurO 3 zon Chairman
More informationA Global Reference in Laboratory Testing. Laboratory excellence to support your testing of biocidal products, detergents and biopesticides
A Global Reference in Laboratory Testing Laboratory excellence to support your testing of biocidal products, detergents and biopesticides Eurofins BioPharma Product Testing Italy c/o Eurofins Biolab Srl
More informationBromuconazole 167 g/l + Tebuconazole 107 g/l EC (SOLEIL) Page 1 of 20. REGISTRATION REPORT Part A. Risk Management
Page 1 of 20 REGISTRATION REPORT Part A Risk Management Product code: Bromuconazole 167 g/l + Tebuconazole 107 g/l EC Product name(s): SOLEIL Active Substance(s): Bromuconazole, 167 g/l Tebuconazole, 107
More informationBackground paper. Food safety in the EU
Background paper Food safety in the EU February 2018 1 The EU s policy on food safety takes an integrated approach and encompasses the entire food chain, from animal feed, animal health, plant protection
More informationFeedback from ECHA on dossier and substance evaluation
Feedback from ECHA on dossier and substance evaluation REACH Implementation Workshop X 13 December 2011 Wim De Coen ECHA Evaluation Unit I Overview Directorate of Evaluation Dossier evaluation Compliance
More informationIntroductory cover note to the List of European Union reference dates and frequency of submission of Periodic Safety Update Reports
24 October 2016 EMA/606369/2012 Rev.15 Procedure Management and Committees Support Introductory cover note to the List of European Union reference dates and frequency of submission of Periodic Safety Update
More informationFACTS. Federal Office for Safety in Health Care
FACTS Federal Office for Safety in Health Care 1 BASG / AGES MEA Federal Office for Safety in Health Care (BASG) and Austrian Medicines and Medical Devices Agency (AGES MEA) The Federal Office for Safety
More informationThe European Agency for the Evaluation of Medicinal Products Work Programme 2003
The European Agency for the Evaluation of Medicinal Products Work Programme 2003 Adopted by the Management Board on 19 December 2002 The Work Programme for 2003 is presented by the Executive Director to
More informationExplanatory note on general fees payable to the European Medicines Agency
Explanatory note on general fees payable to the European Medicines Agency The fees, fee exemptions and definitions described in this explanatory note apply as of 1 June 2017 and are based on Council Regulation
More informationREGISTRATION REPORT Part A. Risk Management. Product code: A16148C Product name(s): VIBRANCE Active Substance(s): Sedaxane, 500g/L
VIBRANCE (A16148C ) Page 1 of 26 Registration Report REGISTRATION REPORT Part A Risk Management Product code: A16148C Product name(s): VIBRANCE Active Substance(s): Sedaxane, 500g/L COUNTRY: FRANCE Zonal
More informationGuideline on good pharmacovigilance practices (GVP)
9 October 2017 EMA/827661/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module IX Signal management (Rev 1) Date of coming into effect of first version 2 July 2012 Draft Revision 1* finalised
More informationGuideline on good pharmacovigilance practices (GVP)
22 June 2012 EMA/827661/2011 (superseded version) Guideline on good pharmacovigilance practices (GVP) Module IX Signal management Draft finalised by the Agency in collaboration with Member States and submitted
More informationVICH Topic GL32 STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: DEVELOPMENTAL TOXICITY TESTING
European Medicines Agency Veterinary Medicines and Inspections CVMP/VICH/485/02-FINAL Updated in June 2004 London, 16 June 2004 VICH Topic GL32 Step 7 STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY
More informationRisk assessment: the bees (including a personal point of view from a private beekeeper)
Risk assessment: the bees (including a personal point of view from a private beekeeper) J. Pistorius (JKI) Bees in the Institute for Plant Protection in Field Crops and Grassland I. Risk assessment of
More informationEUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL QUESTIONS. and ANSWERS
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, F2/SM D (2008) QUESTIONS and ANSWERS The rules governing medicinal products in the European Union VOLUME 2 NOTICE
More informationGuideline on good pharmacovigilance practices (GVP)
1 2 3 19 June 2012 EMA/119871/2012 4 5 Guideline on good pharmacovigilance practices (GVP) Module III Pharmacovigilance inspections Draft finalised by the Agency in collaboration with Member States and
More informationGuideline on the implementation of. European Regulation (EC) 1272/2008
Avenue Jules Bordet, 142 B-1140 Brussels, Belgium Tel: +32 2 761 1653 Fax: +32 2 761 1699 Email: eurobat@kelleneurope.com Guideline on the implementation of European Regulation (EC) 1272/2008 on the classification,
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Medicinal Product quality, safety and efficacy Brussels, 16 August 2013 EudraLex The Rules Governing Medicinal
More informationINTRODUCTION OF FEES TO BE CHARGED BY THE EMA FOR PHARMACOVIGILANCE
Ref. Ares(2012)723154-18/06/2012 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products authorisations, EMA Brussels, D(2012) INTRODUCTION OF FEES TO
More informationVacancy Notice. 1. The job (7)
09.11.2015 1(7) Vacancy Notice The European Chemicals Agency (ECHA) is launching this call for expressions of interest in order to establish a reserve list for the following temporary agent profile: Reference
More informationSafety Measures in the new Pharmacovigilance System
Safety Measures in the new Pharmacovigilance System Dr. Harald Tietz Director Global Patient Safety & Regulatory Affairs, Germany Lilly Deutschland GmbH Documentation and reporting requirements: Centralisation
More informationVariation Regulations (EU)
Variation Regulations (EU) Headlines of the Update APIC c view Hilde Vanneste APIC Task Force leader Hilde.Vanneste@its.jnj.com 1 Content Scope of regulation: Type of procedures and hence 2 strands Current
More informationQuality & Safety GLP. 44 q&more 02/14
Quality & Safety GLP 44 q&more 02/14 More than keeping a lab notebook GLP regulations and their new role in the approval of medicines for advanced therapies (ATMPs) Dr Katja Schellenberg, Translation Centre
More informationPLANNING FOR REACH 2018 AS A NON-EU COMPANY
PLANNING FOR REACH 2018 AS A NON-EU COMPANY Joyce Borkhoff Vice President, Chemicals Group Intertek Scientific & Regulatory Consultancy AGENDA 01 02 Overview of REACH Requirements Specific to Non-EU Companies
More informationPesticide residues in food - Monitoring programs in Europe
Pesticide residues in food - Monitoring programs in Europe Daniela Brocca 48th Annual Florida Pesticide Residue Workshop FPRW 2011 St. Pete Beach, Florida July 17-20, 2011 Content of the presentation 1.
More informationElemental impurities Expectations for APIs and Excipients in the EU
Elemental impurities Expectations for APIs and Excipients in the EU Implementation strategy in the European Pharmacopoeia Dr. Ulrich Rose Head of Division A European Pharmacopoeia Department EDQM 1 Elemental
More informationPolgar ACRO Registration of Pesticides in Russia and Ukraine: Applicants feedback
Polgar ACRO Registration of Pesticides in Russia and Ukraine: Applicants feedback p.tatsiana@polgar-acro.eu Contents Who we are Introduction: Ukraine Overview: timing, steps Costs Authorities and institutions
More informationVariations AGES MEA-LCM-QUAL. Mag. Caroline Kleber. Meet the Case Manager Vienna,
Mag. Caroline Kleber Meet the Case Manager Vienna, 9. 11. 2017 AGES MEA-LCM-QUAL Regulatory Background Commission Regulation (EC) No 1234/2008, amended by No 712/2012 Guidelines of 16.05.2013 on the details
More informationMid term review of EU Ombudsman's verdict regarding DG SANTE's pesticide decision-taking methods.
Mid term review of EU Ombudsman's verdict regarding DG SANTE's pesticide decision-taking methods. (PAN Europe survey, published April 2017). Summary. PAN Europe in 2013 submitted a complaint to the EU
More informationMEDICATED FEEDINGSTUFFS AND SPECIFIED FEED ADDITIVES REGULATION AND APPROVAL OF MANUFACTURERS
MEDICATED FEEDINGSTUFFS AND SPECIFIED FEED ADDITIVES REGULATION AND APPROVAL OF MANUFACTURERS JANIS MCDONALD Medicated Feedingstuffs and Specified Feed Additives Operations Manager VETERINARY MEDICINES
More informationReview of requirements for immunological medicinal products and their evolution since the start of Community legislation on medicines
www.pei.de Review of requirements for immunological medicinal products and their evolution since the start of Community legislation on medicines Dr. Carmen Jungbäck Paul-Ehrlich Institut, Germany London,
More informationModule 1: Administrative information Application form
7 September 2017 CMDh/332/2017/Rev.1 User guide for the electronic application form for a Marketing Authorisation Purpose and general rules This User guide has been prepared in order to facilitate the
More informationREACH REGULATION: the new management of chemicals in Europe and operational tools. R egistration. E valuation. A Ch. uthorisation.
REACH REGULATION: the new management of chemicals in Europe and operational tools R egistration E valuation A Ch uthorisation emicals Index of topics Set of rules before REACH Regulation REACH REGULATION
More informationA regulatory update in a day for Small to Medium-sized Enterprises
TOPRA ANNUAL SYMPOSIUM STOCKHOLM, SWEDEN In partnership with the Swedish Medical Products Agency Time of transformation: Implementing international regulatory change A regulatory update in a day for Small
More informationA GUIDELINE ON DOSSIER REQUIREMENTS FOR TYPE I VARIATIONS November 1999
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Pharmaceuticals and cosmetics Final Revision 0 NOTICE TO APPLICANTS A GUIDELINE ON DOSSIER REQUIREMENTS FOR TYPE I VARIATIONS November 1999 This guideline
More information26/04/2016. Guidelines for emergency situations in plant protection
Guidelines for emergency situations in plant protection Placing on the market of s in accordance with Article 53 of Regulation (EC) No 1107/2009 1 General information Background According to Article 53
More informationInterface between REACH and CAD:
Interface between REACH and CAD: Comparison of central building blocks of risk assessment under both pieces of legislation (DNELs and OELs, RMMs and control measures) 6 th Seminar on Workers Protection
More information(EFSA-Q ) 1 For the purpose of this document foods of animal origin are limited to fresh unprocessed products of animal origin.
1 2 3 4 5 6 7 8 9 10 Joint AFC/BIOHAZ draft guidance document on the submission of data for the evaluation of the safety and the efficacy of substances other than potable water intended to be used to decontaminate
More informationEudraVigilance Veterinary
15 September 2011 EMA/13787/2009 STATUS REPORT TO EMA MANAGEMENT BOARD / VETJIG 1 / PHVWP-V 2 / CVMP 3 / HMA-V 4 / CMD-V 5 This document is published on the EVVet Website: http://eudravigilance.ema.europa.eu/veterinary
More informationThe GMO Imperative. Dr. Eva Claudia Lang Austrian Federal Ministry of Health, Dep. II/B/15. Protecting an Promoting Real Food -Conference
The GMO Imperative Dr. Eva Claudia Lang Austrian Federal Ministry of Health, Dep. II/B/15 Protecting an Promoting Real Food -Conference 22 February 2013, Krakow Overview History Risk assessment of GMOs
More informationImplementation of toxicological data from other legal provisions (e.g. REACH) An industry perspective
Implementation of toxicological data from other legal provisions (e.g. REACH) An industry perspective Dr. Christopher Dobe BfR workshop, Berlin 24 th November 2017 christopher.dobe@syngenta.com Overview
More informationExperience of Post approval change management protocol in EU. Mats Welin Senior expert Medical Products Agency Uppsala, Sweden
Experience of Post approval change management protocol in EU Mats Welin Senior expert Medical Products Agency Uppsala, Sweden Regulatory oversight What is in the filed dossier Descriptions of processes
More informationClinical Trials application process, legislation & guidelines
Clinical Trials application process, legislation & guidelines IMB Clinical Trials Seminar 19 th June 2012 Elaine Breslin MB BCh (NUI), PhD, FRCPI Clinical Assessment Manager 19/06/2012 Slide 1 IMB Mission
More information